Injection of blood products

Hepatitis C - Injection of blood products Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Claimant Report - Transfusion of Blood or Blood Products [CR9012]

Medical Report - Blood Transfusion and Injection of Blood Products - Hepatitis [MR9051]

Preliminary questions [10231]

10249

there is some evidence that a blood products injection may be a factor in the development of the condition under consideration.

7025 the veteran has had a blood product injection at some time.

10250 the veteran had a blood products injection more than 2 weeks before the clinical onset of hepatitis C.

10252

the blood products injection more than 2 weeks before the clinical onset of hepatitis C was screened for hepatitis C.

10253 — the veteran has established the causal connection between the blood product injection and VEA service for the clinical onset of hepatitis C.

10254 — the veteran has established the causal connection between the blood product injection and operational service for the clinical onset of hepatitis C.

or

10255 — the veteran has established the causal connection between the blood product injection and eligible service for the clinical onset of hepatitis C.

Clinical onset and operational service [10254]

11253

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on operational service.

11254

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on operational service, as a causal result of operational service.

11257

the receipt of the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

10251

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given for treatment of an illness or injury which is identifiable.

7029 — the identified illness or injury for which the blood product injection was given is causally related to operational service.

Clinical onset and eligible service [10255]

11255

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on eligible service.

11256

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on eligible service, as a causal result of eligible service duties.

11258

the receipt of the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

10251

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given for treatment of an illness or injury which is identifiable.

10256 — the identified illness or injury for which the blood product injection was given is causally related to eligible service.